These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

813 related items for PubMed ID: 27562333

  • 21. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa.
    Siriyong T, Srimanote P, Chusri S, Yingyongnarongkul BE, Suaisom C, Tipmanee V, Voravuthikunchai SP.
    BMC Complement Altern Med; 2017 Aug 14; 17(1):405. PubMed ID: 28806947
    [Abstract] [Full Text] [Related]

  • 22. SPM-1-producing Pseudomonas aeruginosa ST277 clone recovered from microbiota of migratory birds.
    Martins WMBS, Narciso AC, Cayô R, Santos SV, Fehlberg LCC, Ramos PL, da Cruz JB, Gales AC.
    Diagn Microbiol Infect Dis; 2018 Mar 14; 90(3):221-227. PubMed ID: 29224710
    [Abstract] [Full Text] [Related]

  • 23. Role of efflux pump inhibitor in decreasing antibiotic cross-resistance of Pseudomonas aeruginosa in a burn hospital in Iran.
    Talebi-Taher M, Majidpour َ, Gholami A, Rasouli-Kouhi S, Adabi M.
    J Infect Dev Ctries; 2016 Jun 30; 10(6):600-4. PubMed ID: 27367008
    [Abstract] [Full Text] [Related]

  • 24. Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis.
    Chalhoub H, Sáenz Y, Nichols WW, Tulkens PM, Van Bambeke F.
    Int J Antimicrob Agents; 2018 Nov 30; 52(5):697-701. PubMed ID: 30081137
    [Abstract] [Full Text] [Related]

  • 25. MexXY RND pump of Pseudomonas aeruginosa PA7 effluxes bi-anionic β-lactams carbenicillin and sulbenicillin when it partners with the outer membrane factor OprA but not with OprM.
    Singh M, Sykes EME, Li Y, Kumar A.
    Microbiology (Reading); 2020 Nov 30; 166(11):1095-1106. PubMed ID: 32909933
    [Abstract] [Full Text] [Related]

  • 26. Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa.
    Hocquet D, Nordmann P, El Garch F, Cabanne L, Plésiat P.
    Antimicrob Agents Chemother; 2006 Apr 30; 50(4):1347-51. PubMed ID: 16569851
    [Abstract] [Full Text] [Related]

  • 27. Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Vettoretti L, Plésiat P, Muller C, El Garch F, Phan G, Attrée I, Ducruix A, Llanes C.
    Antimicrob Agents Chemother; 2009 May 30; 53(5):1987-97. PubMed ID: 19258280
    [Abstract] [Full Text] [Related]

  • 28. The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin.
    Puja H, Bolard A, Noguès A, Plésiat P, Jeannot K.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 31964794
    [Abstract] [Full Text] [Related]

  • 29. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.
    Dean CR, Visalli MA, Projan SJ, Sum PE, Bradford PA.
    Antimicrob Agents Chemother; 2003 Mar 24; 47(3):972-8. PubMed ID: 12604529
    [Abstract] [Full Text] [Related]

  • 30. Emergence of colistin resistant Pseudomonas aeruginosa at Tabriz hospitals, Iran.
    Goli HR, Nahaei MR, Ahangarzadeh Rezaee M, Hasani A, Samadi Kafil H, Aghazadeh M.
    Iran J Microbiol; 2016 Feb 24; 8(1):62-9. PubMed ID: 27092226
    [Abstract] [Full Text] [Related]

  • 31. RELATIVE EXPRESSION OF EFFLUX PUMPS IN MULTI DRUG RESISTANT PSEUDOMONAS AERUGINOSA.
    Azimi L, Namvar AE, Jamali S, Lari AR, Bijari A, Lari AR.
    Roum Arch Microbiol Immunol; 2015 Feb 24; 74(3-4):86-90. PubMed ID: 27328522
    [Abstract] [Full Text] [Related]

  • 32. Investigating of four main carbapenem-resistance mechanisms in high-level carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Rostami S, Farajzadeh Sheikh A, Shoja S, Farahani A, Tabatabaiefar MA, Jolodar A, Sheikhi R.
    J Chin Med Assoc; 2018 Feb 24; 81(2):127-132. PubMed ID: 29033110
    [Abstract] [Full Text] [Related]

  • 33. Mechanisms of resistance in clinical isolates of Pseudomonas aeruginosa less susceptible to cefepime than to ceftazidime.
    Campo Esquisabel AB, Rodríguez MC, Campo-Sosa AO, Rodríguez C, Martínez-Martínez L.
    Clin Microbiol Infect; 2011 Dec 24; 17(12):1817-22. PubMed ID: 21599797
    [Abstract] [Full Text] [Related]

  • 34. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.
    Wolter DJ, Smith-Moland E, Goering RV, Hanson ND, Lister PD.
    Diagn Microbiol Infect Dis; 2004 Sep 24; 50(1):43-50. PubMed ID: 15380277
    [Abstract] [Full Text] [Related]

  • 35. Chlorhexidine leads to the evolution of antibiotic-resistant Pseudomonas aeruginosa.
    Tag ElDein MA, Yassin AS, El-Tayeb O, Kashef MT.
    Eur J Clin Microbiol Infect Dis; 2021 Nov 24; 40(11):2349-2361. PubMed ID: 34169445
    [Abstract] [Full Text] [Related]

  • 36. [Two efflux systems expressed simultaneously in clinical Pseudomonas aeruginosa].
    Hocquet D, Llanes C, Patry I, El Garch F, Plésiat P.
    Pathol Biol (Paris); 2004 Oct 24; 52(8):455-61. PubMed ID: 15465264
    [Abstract] [Full Text] [Related]

  • 37. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.
    Adamson DH, Krikstopaityte V, Coote PJ.
    J Antimicrob Chemother; 2015 Aug 24; 70(8):2271-8. PubMed ID: 25921513
    [Abstract] [Full Text] [Related]

  • 38. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
    El Amin N, Giske CG, Jalal S, Keijser B, Kronvall G, Wretlind B.
    APMIS; 2005 Mar 24; 113(3):187-96. PubMed ID: 15799762
    [Abstract] [Full Text] [Related]

  • 39. Mutations in NalC induce MexAB-OprM overexpression resulting in high level of aztreonam resistance in environmental isolates of Pseudomonas aeruginosa.
    Braz VS, Furlan JP, Fernandes AF, Stehling EG.
    FEMS Microbiol Lett; 2016 Aug 24; 363(16):. PubMed ID: 27412168
    [Abstract] [Full Text] [Related]

  • 40. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals.
    Vatcheva-Dobrevska R, Mulet X, Ivanov I, Zamorano L, Dobreva E, Velinov T, Kantardjiev T, Oliver A.
    Microb Drug Resist; 2013 Oct 24; 19(5):355-61. PubMed ID: 23600605
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.